Healthtech startup XRlabs raises £6.3m in seed round
This article covers XRlabs, a London- and Palo Alto-based healthtech startup, and its closing of a seed funding round of £6.3m to advance development of its SurgicalOS platform and related products. The funding will support product development and engagement with device partners as the startup moves SurgicalOS toward commercial readiness, targeting hospitals and health systems including the NHS.
XRlabs, a London- and Palo Alto-based healthtech startup, has closed a seed funding round of £6.3m (announced as $8.4m) to advance development of its SurgicalOS platform and related products. The company says the funding will support product development and engagement with device partners as it moves SurgicalOS toward commercial readiness; SurgicalOS is currently in development and not commercially available.
Why it matters
Surgery is a major target for digitisation and data-driven improvement, and early-stage funding for tools that promise "surgical intelligence" signals continued investor interest in the space. A focused seed raise of this size suggests investors believe there is room for software and systems that integrate operating-room devices, data capture and analytics — particularly from companies with ties to both the UK and US markets.
For the NHS and hospital groups weighing investments in surgical workflows, entrants such as XRlabs are part of a broader wave of healthtech companies aiming to reduce variability, improve device integration and extract actionable insights from procedure data.
Inside the product
Public-facing material from XRlabs lists offerings including XRlabs SIM and SurgicalOS, positioning the firm around surgical intelligence and device partnerships. The company uses the phrase "Surgical Intelligence for every operating room" and highlights activity in London and Palo Alto.
Specific technical details, regulatory status and commercial partners were not disclosed. The firm itself notes that SurgicalOS is in development and not commercially available, which means early adopters will likely see pilot programmes or device integrations before any wider roll-out.
Who are the investors?
XRlabs disclosed the size of the seed funding — £6.3m — but did not name lead backers or participating firms in the announcement. That leaves the investor line-up opaque for now.
Seed rounds of this size in healthtech frequently combine institutional seed funds, specialist healthtech investors and strategic device partners; the company’s reference to device partnerships makes strategic corporate involvement plausible. The raise will place XRlabs alongside other early-stage companies drawing attention from UK healthtech investors focused on surgical workflow, medtech integration and clinical data platforms.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Founder perspective
The announcement did not include quotes or named founder commentary. XRlabs’ public materials emphasise product development and partner engagement rather than commercial availability at this stage.
The bigger picture
The deal fits into a broader pattern of investment into digital surgery and medical software across the UK and Europe, where funders are increasingly backing startups that promise to connect devices, standardise data capture and surface clinical insights. For hospitals and regulatory bodies, the shift raises familiar questions about interoperability, clinical validation and procurement pathways.
For XRlabs, establishing pilots with device partners and demonstrating clinical impact will be critical next steps if it is to convert seed-stage momentum into commercial contracts and regulatory clearances.
The raise also underscores the cross-Atlantic nature of many healthtech ventures: operating between the UK and US can open market opportunities but also demands attention to differing health systems and regulatory regimes in Europe and North America.
Click here for a full list of 7,589+ startup investors in the UK